During the corresponding time, Bard C R Inc recorded a revenue increase by 5.09 % year on year, sequentially revenue grew by 1.03 %. While revenue at the Bard C R Inc's corporate clients
Bard C R Inc's Comment on Sales, Marketing and Customers
The company’s products are distributed domestically directly to hospitals
and other healthcare institutions, as well as through numerous hospital/surgical
supply and other medical specialty distributors with whom the company has distribution
agreements. In international markets, products are distributed either directly
or through distributors, with the practice varying by country. Full-time representatives
of the company in domestic and international markets engage in sales promotion.
Sales to distributors, which supply the company’s products to many end-users,
accounted for approximately 37% of the company’s net sales, and the five
largest distributors combined accounted for approximately 64% of distributors’
sales. One large distributor accounted for approximately 9% of the company’s
net sales.
In order to service its customers, optimize logistics, lower facilities costs
and reduce finished goods inventory levels, the company operates consolidated
distribution facilities in both the United States and Europe. Orders are normally
shipped within a matter of days after receipt. Backlog is not currently a significant
issue for the company.
Most of the products sold by the company, whether manufactured by the company
or by others, are sold under the BARD® trade name or trademark and/or other
trademarks owned by the company. Products manufactured for the company by outside
suppliers are generally produced according to the company’s specifications.
Bard C R Inc’s Comment on Sales, Marketing and Customers
The company’s products are distributed domestically directly to hospitals
and other healthcare institutions, as well as through numerous hospital/surgical
supply and other medical specialty distributors with whom the company has distribution
agreements. In international markets, products are distributed either directly
or through distributors, with the practice varying by country. Full-time representatives
of the company in domestic and international markets engage in sales promotion.
Sales to distributors, which supply the company’s products to many end-users,
accounted for approximately 37% of the company’s net sales, and the five
largest distributors combined accounted for approximately 64% of distributors’
sales. One large distributor accounted for approximately 9% of the company’s
net sales.
In order to service its customers, optimize logistics, lower facilities costs
and reduce finished goods inventory levels, the company operates consolidated
distribution facilities in both the United States and Europe. Orders are normally
shipped within a matter of days after receipt. Backlog is not currently a significant
issue for the company.
Most of the products sold by the company, whether manufactured by the company
or by others, are sold under the BARD® trade name or trademark and/or other
trademarks owned by the company. Products manufactured for the company by outside
suppliers are generally produced according to the company’s specifications.
Sources:
Bard C R Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bard C R Inc’s corporate clients.
For your research, we’ve provided 9 tables on Bard C R Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
